Medicenna to host webinar on Dec.10, 2025 at 08:30 AM EST to discuss updated MDNA11 clinical data.
On December 9, 2025, Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, will hold a live webinar on December 10, 2025, at 8:30 AM Eastern Time. The company, listed on TSX as MDNA and OTCQX as MDNAF, focuses on developing Superkines for treating cancer, autoimmune, and inflammatory conditions. The webinar will be hosted simultaneously in Toronto and Houston.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments